The SUSTAIN-6 trial, which evaluated semaglutide in patients with type 2 diabetes at high cardiovascular risk, identified a statistically significant increase in diabetic retinopathy complications in the semaglutide group compared to placebo
See studies A WALL OF LOVE This is why we do what we do
Its approval follows evidence that, in addition to lowering blood glucose, both Rybelsus and Ozempic benefit heart health by reducing the risk of heart attack, stroke, and heart-related death
1.5-3.0 g/day for one year) in individuals with diabetic peripheral neuropathy (3, 88)
If you miss a dose: Take it as soon as you remember if your next dose is at least 2 days away If less than 2 days remain until next dose, skip missed dose and resume schedule Never inject 2 doses within 2 days[documents.tcurgentcare] Is Tirzepatide Safe for Weight Loss